Trials / Completed
CompletedNCT00427882
Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study
An Open, Non-Comparative, Multicenter Study on the Sexual Function Improvement Following Treatment With Alfuzosin in Patients With Benign Prostate Hyperplasia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 125 (estimated)
- Sponsor
- Handok Inc. · Industry
- Sex
- Male
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Primary: To assess improvement in ejaculation from baseline to the end of treatment (Week 12 or premature withdrawal) with Alfuzosin 10mg OD, using MSHQ score. Secondary: * To evaluate sexual function improvement * To evaluate LUTS (Lower Uninary Tract Symptoms) improvement * To evaluate the association between LUTS severity and sexual function. * To assess the safety and the tolerability of Alfuzosin 10mg OD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ALFUZOSIN |
Timeline
- Start date
- 2006-09-01
- Completion
- 2007-05-01
- First posted
- 2007-01-29
- Last updated
- 2007-11-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00427882. Inclusion in this directory is not an endorsement.